- Home
- PGEN vs STK Comparison
PGEN vs STK Comparison
Compare PGEN & STK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- STK
- Stock Information
- Founded
- PGEN 1998
- STK 2009
- Country
- PGEN United States
- STK United States
- Employees
- PGEN N/A
- STK N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- STK Investment Managers
- Sector
- PGEN Health Care
- STK Finance
- Exchange
- PGEN Nasdaq
- STK Nasdaq
- Market Cap
- PGEN 404.4M
- STK 434.6M
- IPO Year
- PGEN N/A
- STK N/A
- Fundamental
- Price
- PGEN $1.32
- STK $28.33
- Analyst Decision
- PGEN Strong Buy
- STK
- Analyst Count
- PGEN 4
- STK 0
- Target Price
- PGEN $7.33
- STK N/A
- AVG Volume (30 Days)
- PGEN 1.8M
- STK 38.2K
- Earning Date
- PGEN 05-14-2025
- STK 01-01-0001
- Dividend Yield
- PGEN N/A
- STK 6.60%
- EPS Growth
- PGEN N/A
- STK N/A
- EPS
- PGEN N/A
- STK N/A
- Revenue
- PGEN $4,201,000.00
- STK N/A
- Revenue This Year
- PGEN $189.12
- STK N/A
- Revenue Next Year
- PGEN $1,093.07
- STK N/A
- P/E Ratio
- PGEN N/A
- STK N/A
- Revenue Growth
- PGEN N/A
- STK N/A
- 52 Week Low
- PGEN $0.65
- STK $24.95
- 52 Week High
- PGEN $2.17
- STK $34.31
- Technical
- Relative Strength Index (RSI)
- PGEN 44.03
- STK 48.61
- Support Level
- PGEN $1.35
- STK $28.00
- Resistance Level
- PGEN $1.53
- STK $28.94
- Average True Range (ATR)
- PGEN 0.12
- STK 0.41
- MACD
- PGEN 0.00
- STK -0.10
- Stochastic Oscillator
- PGEN 22.22
- STK 16.92
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About STK Columbia Seligman Premium Technology Growth Fund Inc
Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services. Columbia Management Investment Advisers, LLC serves as the investment manager to the fund.